Philip Billaudelle

Philip Billaudelle has a diverse work experience in various roles and industries. Starting in 2011, they worked as a Analysis and Accounting tutor at the University of Mannheim. In 2013, they were a Graduate Research Assistant at the same university and later joined Deloitte as an Auditor. Philip then moved on to work at Volkswagen AG as an Automotive Consultant for a brief period. In 2014, they returned to Deloitte as a Strategy Consultant.

From 2015 to 2020, Philip worked at N26, initially joining as a Business Development Manager and being involved in projects such as banking license application and credit product launch. Philip then took on the role of Group Product Owner, responsible for credit, savings, and investment products. Philip further advanced to become a Data Scientist, developing the company's first machine learning credit risk model for production. Philip later served as the Head of Data Science, managing and growing a team of 10 data scientists and overseeing major projects such as chatbot development and fraud prevention.

In 2021, Philip co-founded Exakt Health and became the CEO. Exakt Health is a medically certified and free physiotherapy app aimed at making injury diagnosis and physiotherapy accessible to everyone.

Philip Billaudelle's education history includes multiple degrees from various institutions. Philip attended the University of Mannheim from 2011 to 2014, where they obtained a Bachelor of Laws (LL.B.) degree in Unternehmensjura with a specialization in Zivilrecht. Additionally, during their time at Mannheim, they pursued a Bachelor of Science (B.Sc.) degree in Business Administration, which they completed from 2010 to 2013.

In 2012, Philip Billaudelle participated in an exchange program and studied at Sciences Po, where they explored subjects such as Political Sciences, Philosophy, Economics, and Entrepreneurship. Before their university studies, they attended the Lycée International Victor Hugo from 2008 to 2010, where they achieved a French-German Baccalauréat "Abibac" with a focus on Sciences.